{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:04:08Z","timestamp":1792173848687,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jconrel.2023.01.012","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T13:36:53Z","timestamp":1673530613000},"page":"260-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice"],"prefix":"10.1016","volume":"354","author":[{"given":"Mohamed","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Helmy","family":"Elgarhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Sarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal K.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.01.012_bb0005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D\u2019souza","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.15171\/bi.2017.09","article-title":"Polymers in our daily life","volume":"7","author":"Namazi","year":"2017","journal-title":"Bioimpacts"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-chembioeng-073009-100847","article-title":"Polymers for drug delivery systems","volume":"1","author":"Liechty","year":"2010","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0020","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/S0021-9258(17)40292-4","article-title":"Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","article-title":"Pegylation","volume":"40","author":"Harris","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0030","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5487\/TR.2015.31.2.105","article-title":"Safety evaluation of polyethylene glycol (PEG) compounds for cosmetic use","volume":"31","author":"Jang","year":"2015","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425240802650568","article-title":"PEG-modified biopharmaceuticals","volume":"6","author":"Bailon","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0045","article-title":"Anti-PEG IgM response against PEGylated liposomes in mice and rats","volume":"3","author":"Ichihara","year":"2011","journal-title":"Pharm."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0050","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijpharm.2012.07.049","article-title":"Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs","volume":"436","author":"Suzuki","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2014.09.047","article-title":"Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin","volume":"476","author":"Suzuki","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0060","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","volume":"292","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0065","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/acs.molpharmaceut.0c00366","article-title":"Impact of pre-existing or induced anti-PEG IgM on the pharmacokinetics of Peginterferon alfa-2a (Pegasys) in mice","volume":"17","author":"Elsadek","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","article-title":"Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes","volume":"112","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0075","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","article-title":"Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents","volume":"9","author":"Garay","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0080","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","article-title":"The mystery of antibodies against polyethylene glycol (PEG) - what do we know?","volume":"33","author":"Lubich","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.toxrep.2020.12.022","article-title":"Flow cytometry analysis of anti-polyethylene glycol antibodies in human plasma","volume":"8","author":"Fang","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Senti","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(02)00462-5","article-title":"Accelerated clearance of PEGylated liposomes in rats after repeated injections","volume":"88","author":"Ishida","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0021-9258(18)70227-5","article-title":"Colorimetric assay methods for free and phosphorylated Glyceric acids","volume":"234","author":"Bartlett","year":"1959","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0105","first-page":"8377","article-title":"In vivo efficacy of recombinant Methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5\u2032-phosphate supplementation","volume":"63","author":"Sun","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0110","article-title":"Bradford assay","volume":"2006","author":"Harlow","year":"2006","journal-title":"CSH Protoc."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.taap.2014.03.002","article-title":"Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs","volume":"277","author":"Hashimoto","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0120","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/acs.molpharmaceut.5b00144","article-title":"Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein","volume":"12","author":"Mima","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2008.06.004","article-title":"Particle size-dependent triggering of accelerated blood clearance phenomenon","volume":"362","author":"Koide","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0130","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s11095-009-9943-x","article-title":"Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles","volume":"26","author":"Ishihara","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0135","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1248\/bpb.b12-00276","article-title":"Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response","volume":"35","author":"Shimizu","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpb.2020.04.026","article-title":"Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice","volume":"152","author":"Elsadek","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0145","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jconrel.2021.05.001","article-title":"Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice","volume":"334","author":"Emam","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0150","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0160","first-page":"690","article-title":"PEG: Will it come Back to you? Polyethelyne glycol immunogenicity, COVID vaccines, and the case for new PEG derivatives and alternatives","author":"Kong","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0165","series-title":"Skin Barrier Function, Karger, Basel","first-page":"26","article-title":"Stratum Corneum lipids: Their role for the skin barrier function in healthy subjects and atopic dermatitis patients","author":"van Smeden","year":"2016"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.2042-7158.1995.tb05725.x","article-title":"The factors that influence skin penetration of solutes*","volume":"47","author":"Abraham","year":"1995","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000091978","article-title":"Overcoming the stratum Corneum: the modulation of skin penetration","volume":"19","author":"Trommer","year":"2006","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.jid.5700582","article-title":"Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients","volume":"127","author":"Jakasa","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2006.08.001","article-title":"Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2005.06.001","article-title":"Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products","volume":"214","author":"Fruijtier-P\u00f6lloth","year":"2005","journal-title":"Toxicol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0200","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600830432","article-title":"Distribution and tissue uptake of poly (ethylene glycol) with different molecular weights after intravenous administration to mice","volume":"83","author":"Yamaoka","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0168-3659(01)00331-5","article-title":"PEG drugs: an overview","volume":"74","author":"Greenwald","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0210","first-page":"1279","article-title":"Microneedles: progress in developing new technology for painless drug delivery","volume":"1","author":"Shivanand","year":"2009","journal-title":"Int. J. Pharm.Tech. Res."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10544-020-00530-3","article-title":"Derma rollers in therapy: the transition from cosmetics to transdermal drug delivery","volume":"22","author":"Dsouza","year":"2020","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0220","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.msec.2019.02.095","article-title":"Derma roller\u00ae microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect","volume":"99","author":"Ahmed","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2023.01.012_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105920","article-title":"Derma roller mediated transdermal delivery of tizanidine invasomes for the management of skeletal muscle spasms","volume":"165","author":"Dsouza","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0041-008X(82)90016-3","article-title":"Toxicity of topical polyethylene glycol","volume":"65","author":"Herold","year":"1982","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0235","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.0022-202X.2004.22413.x","article-title":"Molecular size as the Main determinant of solute maximum flux across the skin","volume":"122","author":"Magnusson","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0240","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/aic.690210522","article-title":"Drug permeation through human skin: theory and invitro experimental measurement","volume":"21","author":"Michaels","year":"1975","journal-title":"AICHE J."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0245","doi-asserted-by":"crossref","first-page":"1900170","DOI":"10.1002\/adtp.201900170","article-title":"Immunogenicity of polyethylene glycol based nanomedicines: mechanisms, clinical implications and systematic approach","volume":"3","author":"d\u2019Avanzo","year":"2020","journal-title":"Adv. Therap."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0250","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4049\/jimmunol.143.4.1239","article-title":"The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence","volume":"143","author":"Dintzis","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0255","doi-asserted-by":"crossref","first-page":"34954","DOI":"10.1038\/srep34954","article-title":"Synergistic efficacy of salicylic acid with a penetration enhancer on human skin monitored by OCT and diffuse reflectance spectroscopy","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0260","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1248\/bpb.b13-00678","article-title":"Effects of oils and emulsifiers on the skin penetration of stearyl glycyrrhetinate in oil-in-water emulsions","volume":"37","author":"Sakata","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0265","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5173(99)00388-9","article-title":"Unexpected skin barrier influence from nonionic emulsifiers","volume":"195","author":"B\u00e1r\u00e1ny","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0270","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0975-7406.92724","article-title":"Status of surfactants as penetration enhancers in transdermal drug delivery","volume":"4","author":"Som","year":"2012","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.jconrel.2023.01.012_bb0275","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar4500","article-title":"Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients","volume":"16","author":"Hershfield","year":"2014","journal-title":"Arthritis Res. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:36:10Z","timestamp":1759163770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":55,"alternative-id":["S0168365923000135"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.012","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}